Bebane S, Denize J, Goujon A, et al. - Given that transurethral resection of bladder tumor (TURBT) represents a fundamental but difficult step in the diagnosis as well as management of non-muscle invasive bladder cancer, and first- and second-look TURBT are central in the treatment of T1 tumors, so, researchers herein retrospectively analyzed all patients who underwent TURBT for T1 urothelial cell carcinoma (UCC) of the bladder in one academic institution between 2007 and 2017. Overall 283 patients took part in this study. Following a mean delay of 54 days, second-look resection was conducted. Experts noted muscle in 85.9% of the samples on the first TURBT. UCC was detected in 52.3% of the samples on the second-look resection. Overall, TURBT represents a challenging procedure, and there is a crucial role of surgeon’s experience in decreasing the postoperative complications rate. The technical difficulties due to the patient's gender, tumor location or number of tumors may be as essential as oncological factors in finalizing whether or not to conduct a second-look resection.